Kalaris Therapeutics Inc
USD4.29
+0.08 (+1.90%)
CEO
Andrew Oxtoby
IPO Date
2020-07-30
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.24
Prev. Close
$4.21
Day Low
$4.16
Day High
$4.34
52W Low
$2.14
52W High
$11.88
Market Cap
$0.08B
Volume
0.01M
| -18.9 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | 32.7% | -441.0% | 0.00 | 0.85 | -112.1 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | 51.2% | -397.2% | -0.11 | 0.69 | -584.1 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -76.3% | -60.0% | 0.13 | 6.69 | -108.7 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -19.8% | -18.8% | 0.02 | 29.39 | -340.8 |
| 31 Dec 2019 | FY | 0.0% | -14447.9% | -19.6% | -17.1% | 0.10 | 13.98 | -1594.9 |
| 31 Dec 2018 | FY | 0.0% | -214.1% | -11.3% | -9.6% | 0.00 | 6.77 | -15646.3 |
| -4.8 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -28.4% | -14.7% | 0.04 | 12.89 | -2.3 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -21.4% | -12.2% | 0.00 | 11.98 | -1.1 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -16.0% | -9.9% | 0.00 | 14.31 | -0.8 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -16.1% | -15.4% | 0.00 | 22.63 | -15.3 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | 42.6% | -1547.5% | -0.10 | 0.16 | -14.0 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -4.7% | -4.3% | 0.07 | 55.08 | -85.1 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -2.8% | -2.4% | 0.15 | 18.48 | -155.6 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | 7.7% | -104.1% | 0.00 | 0.85 | -129.9 |